WHO Target Product Profiles for Monkeypox Therapeutics
25 August 2022
| Technical document
Overview
This document describes the preferred and minimally acceptable profiles for therapeutic agents.
This Target Product Profile (TPP) was developed through a consultation process with key stakeholders in human and animal health, scientific, funding and manufacturing communities.
It is intended to guide and prioritize the evaluation of repurposed therapeutic agents for Monkeypox or the development of new therapeutic agents.
WHO Team
R&D Blue Print (RDB)